SMAD3 and pulmonary fibrosis: Moreover, lncRNA H19 knockdown could reduce the progression of pulmonary fibrosis via the lncRNA H19-miR-140-TGF-β/Smad3 regulatory network, suggesting that lncRNA H19 may serve as an early diagnostic and prognostic biomarker for pulmonary fibrosis [36].